Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cladribine for Early Stage Primary Sclerosing Cholangitis
NCT00004762Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Dec 1994
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of cladribine in Primary Sclerosing Cholangitis (PSC), sponsored by National Center for Research Resources. Primary endpoints: Biochemical parameters (Liver function tests) at 2 years, Radiologic parameters (Cholangiography) at 2 years and 1 more. Started Dec 1994; status: completed.
02
Drugs
cladribine
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT00004762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004762.